【24h】

Stem Cells in the Infarcted Heart

机译:梗死心脏中的干细胞

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Stem cell transplantation is currently generating a significant interest for use in the future treatment of cardiovascular diseases. Stem cell populations are rapidly increasing, and we are still in the search of optimal cell types to use in clinical trials as bone marrow stem cells did not show significant improvement in cardiac function following transplantation. Experimental stem cell studies raised the question on the true differentiation of tissue-specific cell types following transplantation. In fact, recent studies suggest that improved cardiac function is associated with inhibition of apoptosis and fibrosis provided by factors released from stem cells following transplantation. In this review, we will discuss the effects of transplanted stem cells on engraftment and differentiation as well as factors released from stem cells on apoptosis and cardiac remodeling. Keywords Myocardial Infarction - Heart Regeneration - Factors Released from Stem Cells - Teratoma - Cell Transplantation
机译:目前,干细胞移植引起了人们极大的兴趣,可用于将来治疗心血管疾病。干细胞数量正在迅速增加,由于骨髓干细胞在移植后并未显示出明显的心脏功能改善,因此我们仍在寻找可用于临床试验的最佳细胞类型。干细胞实验研究提出了有关移植后组织特异性细胞类型真正分化的问题。实际上,最近的研究表明,心脏功能的改善与移植后干细胞释放的因子对细胞凋亡和纤维化的抑制有关。在这篇综述中,我们将讨论移植的干细胞对移植和分化的影响,以及从干细胞释放的对细胞凋亡和心脏重塑的影响。关键词心肌梗塞-心脏再生-干细胞释放因子-畸胎瘤-细胞移植

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号